Welcome!
RHB Group Research
Broker's Calls
Raffles Medical Group lacks near-term catalysts; RHB keeps 'neutral'
RHB keeps 'neutral' on Raffles Medical Group, as it awaits near-term catalysts.
June 05, 2024
Broker's Calls
Analysts mostly keep estimates on CLAR after 1QFY2024 update
Analysts are mostly unworried by CLAR's lower occupancy following its 1QFY2024 update, mostly keep estimates unchanged.
April 23, 2024
Broker's Calls
Despite drop in FY2023 DPU, analysts remain upbeat on CLAR's outlook
Higher interest rates may have affected CLAR's FY2023, but analysts see more upside in the longer run.
February 05, 2024
Broker's Calls
HRnetGroup to see growth led by economic recovery in Singapore and China: RHB
Strong financial and being a beneficiary of the improving economy keeps HRnetGroup at 'buy': RHB
January 26, 2024
Broker's Calls
RHB lowers target price to $8.20 for City Developments as it awaits stronger performance catalysts
The brokerage house has maintained its “buy” call, although the property developer’s 1HFY2023 performance was “disappointing”.
August 30, 2023
Broker's Calls
RHB upgrades DFI to 'buy' on backing of attractive valuation following drop in share price
Analyst Alfie Yeo anticipates a pick-up in demand in DFI’s markets and improvement in domestic consumption.
August 28, 2023
Singapore economy
Analysts keep earlier growth projections despite official narrowing of GDP growth range
Singapore narrowed its full-year GDP growth projection range to 0.5% to 1.5%, down from its previous estimate of 0.5% to 2.5%.
August 17, 2023
Broker's Calls
Analysts optimistic on ST Engineering, most keep ‘buy’ at raised target prices
Analysts have maintained their positive views on ST Engineering, citing the group's improving results.
August 14, 2023
Broker's Calls
Resilient operating metrics has RHB upgrading call on Starhill Global REIT to 'buy'
RHB has also increased its target price following the REIT’s 2HFY2022/2023 results that were “slightly ahead of expectations".
August 10, 2023
Broker's Calls
Analysts mixed on CICT’s DPU outlook as interest costs expected to increase in 2HFY2023
Analysts from CGS-CIMB and DBS have kept their "buy" and "add" calls, while RHB has stayed "neutral".
August 03, 2023